Clinical significance for diagnosis and prognosis of POP1 and its potential role in breast cancer: a comprehensive analysis based on multiple databases
Open Access
- 9 September 2022
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 14 (17) , 6936-6956
Abstract
Background: Breast cancer (BC) is one of the most common cancers in women. The discovery of available biomarkers is crucial for early diagnosis and improving prognosis. The effect of POP1 in BC remains unrevealed. Our study aims to explore the expression of POP1 in BC and demonstrate its clinical significance and potential molecular mechanisms. Methods: The Cancer Genome Atlas (TCGA) BC cohort transcriptome data and corresponding clinical information were downloaded. GSE42568 cohort, GSE162228 cohort, GSE7904 cohort, and GSE161533 cohort in the Gene Expression Omnibus (GEO) database were used as verification groups. R software and several web tools were used for statistical analysis. Moreover, the proliferation, transwell, wound healing experiments, and flow cytometry were used for in vitro investigation. Results: Compared with normal breast tissue, POP1 expression was up-regulated in BC tissue with a higher mutation rate. POP1 had good diagnostic value for BC and could be utilized as a new marker. POP1 was significantly correlated with multiple pathways in BC and played an important role in the immune infiltration of BC. High-POP1 expression patients were more prone to be responded to immunotherapy and had a significantly higher percentage of immunotherapy response rate. Moreover, POP1 promoted proliferation and migration and inhibited apoptosis in BC cells. Conclusions: POP1 expression was up-regulated in BC and was associated with a poor prognosis. Patients with high-POP1 expression were more likely to be responded to immunotherapy. Our study can provide a potential marker POP1 for BC, which is beneficial in the diagnosis and treatment of BC.Keywords
This publication has 51 references indexed in Scilit:
- Microenvironmental regulation of therapeutic response in cancerTrends in Cell Biology, 2015
- Glioblastoma prognosis linked to neuronal PD-L1 expression in tumour-adjacent tissueNature Reviews Neurology, 2013
- Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343Journal of Clinical Oncology, 2013
- Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T CellsClinical Cancer Research, 2010
- The cytoskeleton and cancerCancer and Metastasis Reviews, 2009
- Mapping of POP1-binding Site on Pyrin Domain of ASCJournal of Biological Chemistry, 2008
- Subclass Mapping: Identifying Common Subtypes in Independent Disease Data SetsPLOS ONE, 2007
- Breast cancerThe Lancet, 2005
- Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasionNature Medicine, 2002
- Mouse Pop1 Is Required for Muscle Regeneration in Adult Skeletal MuscleMolecular and Cellular Biology, 2002